AGLE logo

Aeglea BioTherapeutics (AGLE) Return On Assets

Annual ROA

-92.58%
-44.12%-91.04%

December 31, 2022


Summary


Performance

AGLE ROA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherAGLEprofitabilitymetrics:

Quarterly ROA

-205.04%
+35.99%+14.93%

September 30, 2023


Summary


Performance

AGLE Quarterly ROA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherAGLEprofitabilitymetrics:

ROA Formula

ROA =  Net Income
Total Assets
✕ 100%

AGLE ROA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-91.0%-149.8%
3 y3 years+4.8%-196.8%
5 y5 years-109.3%-262.2%

AGLE ROA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year+91.0%at low+343.2%+17.6%
5 y5-year+91.0%+5.1%+399.1%+17.6%
alltimeall time+216.8%+281.4%+674.9%+72.2%

Aeglea BioTherapeutics ROA History

DateAnnualQuarterly
Sep 2023
-
-205.04%(-14.9%)
Jun 2023
-
-241.03%(+151.0%)
Mar 2023
-
-96.04%(+6.0%)
Dec 2022
-92.58%(+91.0%)
-90.61%(+10.4%)
Sep 2022
-
-82.09%(+8.0%)
Jun 2022
-
-75.99%(+33.5%)
Mar 2022
-
-56.91%(+23.0%)
Dec 2021
-48.46%(-26.7%)
-46.26%(+2.9%)
Sep 2021
-
-44.97%(+9.5%)
Jun 2021
-
-41.08%(-26.6%)
Mar 2021
-
-55.93%(-11.8%)
Dec 2020
-66.09%(-32.0%)
-63.38%(-8.3%)
Sep 2020
-
-69.09%(-10.6%)
Jun 2020
-
-77.27%(-4.3%)
Mar 2020
-
-80.77%(+4.7%)
Dec 2019
-97.26%
-77.17%(+6.6%)
Sep 2019
-
-72.36%(+10.8%)
Jun 2019
-
-65.30%(-0.4%)
DateAnnualQuarterly
Mar 2019
-
-65.59%(-1.0%)
Dec 2018
-66.28%(+49.8%)
-66.27%(+17.1%)
Sep 2018
-
-56.61%(+11.2%)
Jun 2018
-
-50.91%(+3.1%)
Mar 2018
-
-49.37%(+13.1%)
Dec 2017
-44.24%(+7.8%)
-43.64%(+9.1%)
Sep 2017
-
-39.99%(+12.1%)
Jun 2017
-
-35.67%(-4.5%)
Mar 2017
-
-37.35%(+0.1%)
Dec 2016
-41.05%(+40.5%)
-37.33%(-1.8%)
Sep 2016
-
-38.02%(+4.7%)
Jun 2016
-
-36.32%(+10.0%)
Mar 2016
-
-33.03%(+24.8%)
Dec 2015
-29.22%(-91.7%)
-26.46%(-14.8%)
Sep 2015
-
-31.07%(-6.8%)
Jun 2015
-
-33.34%(-30.2%)
Mar 2015
-
-47.78%(-86.5%)
Dec 2014
-353.14%
-353.14%

FAQ

  • What is Aeglea BioTherapeutics annual return on assets?
  • What is the all time high annual ROA for Aeglea BioTherapeutics?
  • What is Aeglea BioTherapeutics annual ROA year-on-year change?
  • What is Aeglea BioTherapeutics quarterly return on assets?
  • What is the all time high quarterly ROA for Aeglea BioTherapeutics?
  • What is Aeglea BioTherapeutics quarterly ROA year-on-year change?

What is Aeglea BioTherapeutics annual return on assets?

The current annual ROA of AGLE is -92.58%

What is the all time high annual ROA for Aeglea BioTherapeutics?

Aeglea BioTherapeutics all-time high annual return on assets is -29.22%

What is Aeglea BioTherapeutics annual ROA year-on-year change?

Over the past year, AGLE annual return on assets has changed by -44.12% (-91.04%)

What is Aeglea BioTherapeutics quarterly return on assets?

The current quarterly ROA of AGLE is -205.04%

What is the all time high quarterly ROA for Aeglea BioTherapeutics?

Aeglea BioTherapeutics all-time high quarterly return on assets is -26.46%

What is Aeglea BioTherapeutics quarterly ROA year-on-year change?

Over the past year, AGLE quarterly return on assets has changed by -122.95% (-149.77%)